NCT06846086View on ClinicalTrials.gov

Cardioprotective Effects of Melatonin in Patients With Cardiomyopathy

PHASE3RecruitingINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

February 20, 2025

Primary Completion Date

January 1, 2026

Study Completion Date

February 1, 2026

Conditions

Cardiomyopathies

Interventions

DRUG

Melatonin 10 MG

Melatonin

DRUG

Placebo

placebo

Trial Locations (1)

35516

RECRUITING

Mansoura University Hospital, Dakahlia, Egypt

All Listed Sponsors

lead

Tanta University

OTHER